Pharmacia Articles

Bulgaria's Pharmacia aiming to meet GMP production standards

5 March 1999

-Taisho's Rogaine approved in Japan

4 March 1999

Stock Commentary Tokyo

4 March 1999

Meiji Seika goes abroad to strengthen R&D

26 February 1999

P&U licenses NeoPharm drugs in $65M deal

25 February 1999

MGI starts trials of MGI 114 in combination

25 February 1999

Pharmacia & Upjohn sells last Spanish plant

23 February 1999

Future growth of the global pharmaceutical market evaluated by MSDW

23 February 1999

-Pharmacia & Upjohn appoints Peter Stevenson

23 February 1999

Drug majors settle pricing lawsuit in USA

22 February 1999

Canada's Technilab makes acquisition

16 February 1999

Healthy revenue rises at Genset SA

12 February 1999

P&U posts strong growth for 1998

12 February 1999

Swedish pharma market sees 16.2% growth for 1998, says LIF

12 February 1999

Bioject - one step ahead in a needle-free world

10 February 1999

Sumitomo to distribute LJL products in Japan

5 February 1999

Abbokinase contamination warning issued by FDA - shipments to resume with

4 February 1999

Stock Commentary Europe

4 February 1999

Weston Medical signs Intraject deal with P&U

4 February 1999

InSite Vision licenses glaucoma treatment

4 February 1999

Abbokinase contamination warning issued by FDA - shipments to resume with

3 February 1999

Pharmacia & Upjohn's Nicorette Inhaler achieves 15% market share in UK

26 January 1999

P&U amends Miravant deal up to $41.5 million

20 January 1999

Stock Commentary Tokyo

14 January 1999

New President for Novartis Nutrition

14 January 1999

Stock Commentary Europe

14 January 1999

Balkanpharma-Sofia investment program for Pharmacia

11 January 1999

P&U New President of US Consumer Healthcare

7 January 1999

Alza's Ditropan XL cleared by FDA- updated story

7 January 1999

Stock Commentary Tokyo

7 January 1999

Mergers & acquisitions in 1998: a lot of wooing but disappointment at the

7 January 1999

Swedish govt selling rest of stake in P&U

5 January 1999

Euro drug industry "falling behind USA"

18 December 1998

Robert Salisbury Joins Viragen As Director

17 December 1998

Stock Commentary Europe

17 December 1998

GW, SB Lining Up Offers For Zeneca?

15 December 1998

HMO Stops Supplying Zantac, Xanax, Mevacor

8 December 1998

Nycomed-Amersham Getting Over Transformation

4 December 1998

IntraBiotics Receives Milestone Payment From Pharmacia & Upjohn

3 December 1998

US Drug Price-Fixing Claims Dismissed

2 December 1998

P&U's Vantin Approved By FDA

26 November 1998

Stock Commentary Europe

19 November 1998

Viagra "Should Be Prescribed On UK NHS"

18 November 1998

New Pharmacia & Upjohn Vice President

12 November 1998

Stock Commentary Europe

5 November 1998

Pharmacia & Upjohn Posts Strong Growth For 3rd Qtr

3 November 1998

Healthy Revenue Rises At Genset SA

26 October 1998

Antisense '98 - The Key Players In R&D

22 October 1998

Quality Control At P&U

19 October 1998

Argonex appoints Mark Braughler president

15 October 1998

New Antibacterials Showcased At ICAAC

14 October 1998

S-P Launches Detrunorm In UK

8 October 1998

B-MS Licenses Unilever Hair Research

8 October 1998

World Pharma Market Sales Leaders

6 October 1998

Genset And P&U In Pharmacogenomics Deal

5 October 1998

Stock Commentary Europe

30 September 1998

US Seniors "Pay Up To 1,407% More For Rx Drugs"

29 September 1998

First Approval Of DuPont's Sustiva In USA

21 September 1998

Nycomed Amersham Acquires Molecular Dynamics.

17 September 1998

Baxter Drops Blood Substitute

17 September 1998

P&U Gains Miglitol Rights

10 September 1998

Neurosearch Has Five Products In Clinical Development

1 September 1998

Stock Commentary Europe

20 August 1998

Nycomed Amersham To Buy Molecular Dynamics

11 August 1998

Many US Companies Go Into The Black For 2nd Qtr

5 August 1998

Pharmacia & Upjohn Turnaround Continuing

31 July 1998

Euro Commission To Back Biotech Start-Ups

28 July 1998

Tanabe Appointment

23 July 1998

Appointments At P&U

16 July 1998

Four Drug Majors Settle Pharmacy Pricing Suit

15 July 1998

First Approval For Senetek's Invicorp

14 July 1998

New Treasurer At P&U

9 July 1998

P&U Gains Rights To NeuroSearch Anxiolytic

9 July 1998

Stock Commentary New York

9 July 1998

Stock Commentary Europe

2 July 1998

Agouron Shopping For HIV Portfolio

1 July 1998

Detrol Doing Well

30 June 1998

P&U Diabetes License

25 June 1998

Phase III Data With Hyal/Shire's HyClinda

18 June 1998

Mirapex May Help PD Tremor, Say New Data

18 June 1998

Stock Commentary Europe

18 June 1998

P&U Sells Nutrition Business To Fresenius

15 June 1998

Dramatic Growth Seen In Europe's Biotech Sector

4 June 1998

Baxter Suspends HemAssist Trial In Europe

4 June 1998

Industry "Must Set Goals For The Millennium"

28 May 1998

Stock Commentary Europe

28 May 1998

Taxol, Platinum "Optimal" For Ovarian Cancer

27 May 1998

New Drug Targets "Will Not Be Met"

22 May 1998

Genetics Institute And Wyeth-Ayerst File For ReFacto Approval

21 May 1998

Appointment At Eurona Medical

21 May 1998

Novo Nordisk And Ares-Serono Settle Growth Hormone Suit

19 May 1998

Nycomed Amersham Early-Year Growth "As Expected"

19 May 1998

Strong 1st Qtr Growth In Swedish Pharma Market

15 May 1998

Merck & Co's Propecia "Not Effective In Women"

14 May 1998

Northfield And P&U Start PolyHeme Studies

14 May 1998

Mixed Fortunes For US Companies In 1st Qtr

14 May 1998

Stock Commentary Europe

14 May 1998

Unapproved Drugs Imported Into Japan

8 May 1998

P&U Files NDA For Reboxetine

7 May 1998

Viagra Phenomenon Set To Transform Pharma Industry

6 May 1998

Showing 801-900 of 1436 articles

Go to beginningPreviousNextGo to end